Multi-omics analysis of HLTF context-dependent regulation across TCGA cohorts revealed its potential as new biomarker in tumour
Open Access
- 24 July 2026
- journal article
- research article
- Published by Springer Nature in Mammalian Genome
- Vol. 37 (1) , 92
Abstract
The SNF2-family Helicase-Like Transcription Factor (HLTF) has been implicated in tumorigenesis, with evidence suggesting both tumour-suppressive and oncogenic functions. To clarify the nature of this increasingly emerging double function, we analysed the full HLTF’s alterome across TCGA cohorts combining first gene expression with genomic and epigenomic layers of de-regulation, and investigating further their determinants through the integration of DNA methylation profiles - both at promoter-proximal and distal regions, the copy-number alterations, and all somatic mutations. This multi-layered analysis highlighted specific context-dependent HLTF’s regulatory configurations across human cancers, even modulated by either dosage effects or loss-of-function events. The clinical relevance of HLTF’s alterations, identified through tumour-specific associations with patient outcomes, supports its potential as new biomarker in cancer overall.Keywords
This publication has 52 references indexed in Scilit:
- Computational study of the HLTF ATPase remodeling domain suggests its activity on dsDNA and implications in damage toleranceJournal of Structural Biology, 2024
- The fork remodeler helicase-like transcription factor in cancer development: all at onceBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2024
- SMARCAL1 is a dual regulator of innate immune signaling and PD-L1 expression that promotes tumor immune evasionCell, 2024
- Gene dosage compensation: Origins, criteria to identify compensated genes, and mechanisms including sensor loops as an emerging systems‐level property in cancerCancer Medicine, 2023
- HLTF Promotes Fork Reversal, Limiting Replication Stress Resistance and Preventing Multiple Mechanisms of Unrestrained DNA SynthesisMolecular Cell, 2020
- Promoter DNA Hypermethylation and Paradoxical Gene ActivationTrends in Cancer, 2020
- Predicting Functional Effect of Human Missense Mutations Using PolyPhen‐2Current Protocols in Human Genetics, 2013
- The Helicase-Like Transcription Factor and its implication in cancer progressionCellular and Molecular Life Sciences, 2007
- The Epigenomics of CancerCell, 2007
- Comparison of DNA hypermethylation patterns in different types of uterine cancer: Cervical squamous cell carcinoma, cervical adenocarcinoma and endometrial adenocarcinomaInternational Journal of Cancer, 2005